Salomon & Ludwin’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6K Hold
904
– – ﹤0.01% 1056
2026
Q2
$13.5K Buy
+904
New +$8.72K ﹤0.01% 1433
2026
Q1
– Sell
-998
Closed -$12.1K – 2159
2025
Q4
$12.1K Sell
998
-1
-0.1% -$11 ﹤0.01% 1320
2025
Q3
$9.09K Buy
+999
New +$7K ﹤0.01% 1382

Other funds holding NEO

Salomon & Ludwin's NEO Position: Q3 2026 in Review

Salomon & Ludwin held its NeoGenomics (NEO) position steady in Q3 2026 at 904 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Salomon & Ludwin first reported a position in NEO in Q3 2025 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Salomon & Ludwin held 904 shares of NeoGenomics worth $16.6K as of Q3 2026.
  • Salomon & Ludwin left its NeoGenomics share count unchanged in Q3 2026.
  • NeoGenomics made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1056 holding.
  • Salomon & Ludwin first reported a position in NeoGenomics in Q3 2025 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.